2,376
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles

, , , , ORCID Icon, , & show all
Pages 2229-2240 | Received 26 Aug 2021, Accepted 04 Oct 2021, Published online: 20 Oct 2021

References

  • Abou-Taleb HA , Khallaf RA , Abdel-Aleem JA. (2018). Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation. Drug Des Devel Ther 12: 3501–16.
  • Ahmed OAA , Kurakula M , Banjar ZM , et al. (2015). Quality by design coupled with near infrared in formulation of transdermal glimepiride liposomal films. J Pharm Sci 104: 2062–75.
  • Alghaith AF , Alshehri S , Alhakamy NA , Hosny KM. (2021). Development, optimization and characterization of nanoemulsion loaded with clove oil-naftifine antifungal for the management of tinea. Drug Deliv 28: 343–56.
  • Alhakamy NA , Badr-Eldin SM , A Fahmy U , et al. (2020). Thymoquinone-Loaded Soy-phospholipid-based phytosomes exhibit anticancer potential against human lung cancer cells. Pharmaceutics 12: 761.
  • Alkhalidi HM , Naguib GH , Kurakula M , et al. (2018). In vitro and preclinical assessment of factorial design based nanoethosomal transdermal film formulation of mefenamic acid to overcome barriers to its use in relieving pain and inflammation. J Drug Deliv Sci Technol 48: 450–6.
  • Anwar M , Muhammad F , Akhtar B , et al. (2020). Nephroprotective effects of curcumin loaded chitosan nanoparticles in cypermethrin induced renal toxicity in rabbits. Environ Sci Pollut Res Int 27: 14771–9.
  • Baldisserotto B , Parodi TV , Stevens ED. (2018). Lack of postexposure analgesic efficacy of low concentrations of eugenol in zebrafish. Vet Anaesth Analg 45: 48–56.
  • Bellmann R , Smuszkiewicz P. (2017). Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection 45: 737–79.
  • Buss N , Snell P , Bock J , et al. (2001). Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration. Br J Clin Pharmacol 52: 255–64.
  • Cao SL , Ren XW , Zhang QZ , et al. (2009). In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Int J Pharm 365: 109–15.
  • Cevc G , Blume G. (2003). Biological activity, and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. Biochim Biophys Acta 1614: 156–64. 7
  • Chakrabarti A , Das A , Panda NK. (2009). Controversies surrounding the categorization of fungal sinusitis. Med Mycol 47: S299–S308.
  • Chris Rathbun R , Hoffman HL. (2002). Review of the safety and efficacy of voriconazole. Expert Opin Investig Drugs 11: 409–29.
  • Darvishi E , Omidi M , Bushehri AAS , et al. (2013). The antifungal eugenol perturbs dual aromatic and branched-chain amino acid permeases in the cytoplasmic membrane of yeast. PLoS One 8: e76028.
  • Dervis E , Yurt Kilcar A , Medine EI , et al. (2017). In vitro incorporation of radioiodinated eugenol on adenocarcinoma cell lines (Caco2, MCF7, and PC3). Cancer Biother Radiopharm 32: 75–81.,
  • El Maghraby GM , Williams AC , Barry BW. (2000). Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 196: 63–74. 25
  • El-Emam GA , Girgis GNS , El-Sokkary MMA , et al. (2020). Ocular inserts of voriconazole-loaded proniosomal gels: formulation, evaluation and microbiological studies. Int J Nanomedicine 15: 7825–40.
  • Galgatte UC , Kumbhar AB , Chaudhari PD. (2014). Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation. Drug Deliv 21: 62–73.
  • Guo J , Ping Q , Sun G , Jiao C. (2000). Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int J Pharm 194: 201–7.
  • Gupta A , Aggarwal G , Singla S , Arora R. (2012). Transfersomes: a novel vesicular carrier for enhanced transdermal delivery of sertraline, development, characterization, and performance evaluation. Sci Pharm 80: 1061–80.
  • Hamed SF , Sadek Z , Edris A. (2012). Antioxidant and antimicrobial activities of clove bud essential oil and eugenol nanoparticles in alcohol-free microemulsion. J Oleo Sci 61: 641–8.
  • Herbrecht R. (2004). Voriconazole: therapeutic review of a new azole antifungal. Expert Rev anti Infect Ther 2: 485–97.
  • Hosny KM , Alhakamy NA , Sindi AM , Khallaf RA. (2020). Coconut oil nanoemulsion loaded with a statin hypolipidemic drug for management of burns, formulation and in vivo evaluation. Pharmaceutics 7: 1061.
  • Hosny KM , Alhakamy NA. (2020). Nasal gel loaded with amphotericin nanotransferosomes as antifungal treatment for fungal sinusitis. Pharmaceutics 13: 35.
  • Hosny KM , Rizg WY , Khallaf RA. (2020). Preparation and optimization of in situ gel loaded with rosuvastatin-ellagic acid nanotransfersomes to enhance the anti-proliferative activity. Pharmaceutics 12: 263.
  • Hosny KM , Sindi AM , Alkhalidi HM , et al. (2021). Development of omega-3 loxoprofen-loaded nanoemulsion to limit the side effect associated with NSAIDs in treatment of tooth pain. Drug Deliv 28: 741–51.
  • Jeu L , Piacenti FJ , Lyakhovetskiy AG , Fung HB. (2003). Voriconazole. Clin Ther 25: 1321–81.
  • Jogani V , Jinturkar K , Vyas T , Misra A. (2008). Recent patents review on intranasal administration for CNS drug delivery. Recent Pat Drug Deliv Formul 2: 25–40.
  • Khajeh M. (2009). Application of Box-Behnken design in the optimization of a magnetic nanoparticle procedure for zinc determination in analytical samples by inductively coupled plasma optical emission spectrometry. J Hazard Mater 172: 385–9. 15
  • Khallaf RA , Aboud HM , Sayed OM. (2020). Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation. J Liposome Res 30: 163–73.
  • Kim SS , Oh OJ , Min HY , et al. (2003). Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264. 7 cells. Life Sci 73: 337–48.
  • Laverdiere M , Bow EJ , Rotstein C , et al. (2014). Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective. Can J Infect Dis Med Microbiol 25: 327–43.
  • Lee SJ , Han JI , Lee SHG , et al. (2007). Antifungal effect of eugenol and nerolidol against microsporum gypseum in a guinea pig model. Biol Pharm Bull 30: 184–8.
  • Maertens JA , Raad II , Marr KA , et al. (2016). Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet 387: 760–9. 20
  • Maheshwari RG , Tekade RK , Sharma PA , et al. (2012). Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi Pharm J 20: 161–70.
  • Mahtab A , Anwar M , Mallick N , et al. (2016). Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS PharmSciTech 17: 1477–90.
  • Miranda-Cadena K , Marcos-Arias C , Mateo E , et al. (2018). Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis. Arch Oral Biol 95: 100–7.
  • Montone KT. (2014). Recent considerations in the classification and pathogenesis of fungal rhinosinusitis. In: pathobiology of human disease, a dynamic encyclopedia of disease mechanisms. Amsterdam, The Netherlands: Elsevier. pp. 1432–44.
  • Montone KT. (2016). Pathology of fungal rhinosinusitis: a review. Head Neck Pathol 10: 40–6.
  • Mutalik S , Udupa N. (2003). Effect of some penetration enhancers on the permeation of glibenclamide and glipizide through mouse skin. Pharmazie 58: 891–4.
  • Patra JK , Das G , Fraceto LF , et al. (2018). Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 16: 71.
  • Qushawy M , Nasr A , Abd-Alhaseeb M , Swidan S. (2018). Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics 10: 26.
  • Raju YP , Hyndavi N , Chowdary VH , et al. (2017). In vitro assessment of non-irritant microemulsified voriconazole hydrogel system. Artif Cells Nanomed Biotechnol 45: 1539–47.
  • Rençber S , Karavana SY. (2018). Development and in vitro evaluation of voriconazole nanoparticle formulation for mucosal application.Turk J Pharm Sci 15:142–8.
  • Salem HF , El-Menshawe SF , Khallaf RA , Rabea YK. (2020). A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension, optimization using Box-Benkhen design, in vitro and in vivo characterization.Drug Deliv Transl Res 10:227–40.
  • Salem HF , Nafady MM , Ewees MGE , et al. (2021). Rosuvastatin calcium-based novel nanocubic vesicles capped with silver nanoparticles-loaded hydrogel for wound healing management: optimization employing Box-Behnken design, in vitro and in vivo assessment.J Liposome Res 11:1–17.
  • Scott LJ , Simpson D. (2007). Voriconazole : a review of its use in the management of invasive fungal infections.Drugs 67:269–98.
  • Singh NK , Lee DS. (2014). In situ gelling pH- and temperature-sensitive biodegradable block copolymer hydrogels for drug delivery.J Control Release 193:214–27.
  • Singh RM , Kumar A , Pathak K. (2013). Thermally triggered mucoadhesive in situ gel of loratadine: β-cyclodextrin complex for nasal delivery.AAPS PharmSciTech 14:412–24.
  • Somani SM , Husain K , Whitworth C ,et al. (2000). Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats, Antioxidant defense system.Pharmacol Toxicol 86:234–41.
  • Srinivas P , Sreeja K. (2013). Formulation and evaluation of voriconazole loaded nanospongesfor oral and topical delivery.Int J Drug Dev Res 5:55–69.
  • Zhang H , Chen X , He JJ. (2009). Pharmacological action of clove oil and its application in oral care products.Oral Care Industry 19:23–4.
  • Zhu L , Ao J , Li P. (2015). A novel in situ gel base of deacetylase gellan gum for sustained ophthalmic drug delivery of ketotifen: in vitro and in vivo evaluation.Drug Des Devel Ther 29:3943–9.